Loading…
Based on limited metadata, One Stop Pharma received an FDA Warning Letter on May 29, 2018, though the specific violations and subject matter are not detailed in the available information. The letter appears to relate to pharmaceutical or pharmacy operations, categorized as "Other" product type, but without access to the full document text, the precise nature of the regulatory concerns cannot be determined. The issuing office is also not specified in the metadata provided. To understand the specific violations and required corrective actions, review of the complete Warning Letter would be necessary.